Literature DB >> 29255995

Effectiveness of Pharmacological Treatment for Attention-Deficit/Hyperactivity Disorder on Physical Injuries: A Systematic Review and Meta-Analysis of Observational Studies.

Kenneth K C Man1,2,3,4,5, Patrick Ip5, Esther W Chan1, Siew-Ling Law3, Miriam T Y Leung1, Evelyn X Y Ma3, Wan-Ting Quek3, Ian C K Wong6,7,8.   

Abstract

BACKGROUND: Patients with attention-deficit/hyperactivity disorder (ADHD) are more prone to physical injuries, including motor vehicle accidents, fractures and brain injuries. Several observational studies have been published investigating the association between the use of pharmacological treatment for ADHD and the incidence of physical injuries among patients with ADHD; however, the findings are not concordant.
OBJECTIVE: This study is a systematic review and meta-analysis of the existing literature and estimates the overall association between the use of ADHD medications and physical injury. Injury is defined as medically attended physical injuries in the form of hospitalisations, emergency department visits or general practitioners visits.
METHODS: The PubMed, EMBASE, PsycINFO, CINAHL and Cochrane Review databases were searched for relevant studies published up to May 2017 relating to ADHD medication and risk of injuries. Observational studies with any study design, all age groups (children and adults) and all ADHD medications (stimulant and non-stimulants) were included. Studies relevant to the association between ADHD medication exposure and risk of injuries in ADHD patients were extracted and compiled for meta-analysis. Both within-individual and between-individual analyses were conducted.
RESULTS: Overall, 2001 citations were identified and 10 observational studies were included. Three self-controlled case series and two self-controlled cohorts were eligible for meta-analysis of within-individual studies. Five cohort studies were included in the meta-analysis of between-individual studies. The adjusted rate ratio of the within-individual methods was 0.76 (95% confidence interval [CI] 0.61-0.93) and 0.88 (95% CI 0.85-0.92) for between-individual studies.
CONCLUSION: The findings of this meta-analysis support a reduced risk of injuries among ADHD patients who were treated with ADHD medications.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29255995     DOI: 10.1007/s40263-017-0485-1

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  18 in total

1.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

2.  Association Between Medication Use for Attention-Deficit/Hyperactivity Disorder and Risk of Motor Vehicle Crashes.

Authors:  Zheng Chang; Patrick D Quinn; Kwan Hur; Robert D Gibbons; Arvid Sjölander; Henrik Larsson; Brian M D'Onofrio
Journal:  JAMA Psychiatry       Date:  2017-06-01       Impact factor: 21.596

3.  The risk of injury in adults with attention-deficit hyperactivity disorder: A nationwide, matched-cohort, population-based study in Taiwan.

Authors:  Wu-Chien Chien; Chi-Hsiang Chung; Fu-Huang Lin; Chin-Bin Yeh; San-Yuan Huang; Ru-Band Lu; Hsin-An Chang; Yu-Chen Kao; Wei-Shan Chiang; Yu-Ching Chou; Chang-Huei Tsao; Yung-Fu Wu; Nian-Sheng Tzeng
Journal:  Res Dev Disabil       Date:  2017-05-02

4.  Mortality associated with attention-deficit hyperactivity disorder (ADHD) drug treatment: a retrospective cohort study of children, adolescents and young adults using the general practice research database.

Authors:  Suzanne McCarthy; Noel Cranswick; Laura Potts; Eric Taylor; Ian C K Wong
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

5.  Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study.

Authors:  Zheng Chang; Paul Lichtenstein; Brian M D'Onofrio; Arvid Sjölander; Henrik Larsson
Journal:  JAMA Psychiatry       Date:  2014-03       Impact factor: 21.596

6.  Association between ADHD drug use and injuries among children and adolescents.

Authors:  Els van den Ban; Patrick Souverein; Willemijn Meijer; Herman van Engeland; Hanna Swaab; Toine Egberts; Eibert Heerdink
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-06-04       Impact factor: 4.785

7.  Attention deficit hyperactivity disorder and increased risk of injury.

Authors:  R M Merrill; J L Lyon; R K Baker; L H Gren
Journal:  Adv Med Sci       Date:  2009       Impact factor: 3.287

8.  Methylphenidate and the risk of trauma.

Authors:  Kenneth K C Man; Esther W Chan; David Coghill; Ian Douglas; Patrick Ip; Ling-Pong Leung; Matthew S H Tsui; Wilfred H S Wong; Ian C K Wong
Journal:  Pediatrics       Date:  2014-12-15       Impact factor: 7.124

9.  Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system.

Authors:  K K C Man; D Coghill; E W Chan; W C Y Lau; C Hollis; E Liddle; T Banaschewski; S McCarthy; A Neubert; K Sayal; P Ip; I C K Wong
Journal:  Transl Psychiatry       Date:  2016-11-15       Impact factor: 6.222

Review 10.  Medication safety research by observational study design.

Authors:  Kim S J Lao; Celine S L Chui; Kenneth K C Man; Wallis C Y Lau; Esther W Chan; Ian C K Wong
Journal:  Int J Clin Pharm       Date:  2016-03-22
View more
  8 in total

Review 1.  Risks and Benefits of Attention-Deficit/Hyperactivity Disorder Medication on Behavioral and Neuropsychiatric Outcomes: A Qualitative Review of Pharmacoepidemiology Studies Using Linked Prescription Databases.

Authors:  Zheng Chang; Laura Ghirardi; Patrick D Quinn; Philip Asherson; Brian M D'Onofrio; Henrik Larsson
Journal:  Biol Psychiatry       Date:  2019-04-17       Impact factor: 13.382

2.  Attention-Deficit/Hyperactivity Disorder Medication and Unintentional Injuries in Children and Adolescents.

Authors:  Laura Ghirardi; Henrik Larsson; Zheng Chang; Qi Chen; Patrick D Quinn; Kwan Hur; Robert D Gibbons; Brian M D'Onofrio
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2019-07-11       Impact factor: 8.829

3.  Attention-Deficit/Hyperactivity Disorder and Mortality Risk in Taiwan.

Authors:  Vincent Chin-Hung Chen; Hsiang-Lin Chan; Shu-I Wu; Meng Lee; Mong-Liang Lu; Hsin-Yi Liang; Michael E Dewey; Robert Stewart; Charles Tzu-Chi Lee
Journal:  JAMA Netw Open       Date:  2019-08-02

4.  Prevalence of ADHD in Accident Victims: Results of the PRADA Study.

Authors:  Sarah Kittel-Schneider; Sarah Wolff; Kristin Queiser; Leonie Wessendorf; Anna Maria Meier; Moritz Verdenhalven; Nathalie Brunkhorst-Kanaan; Oliver Grimm; Rhiannon McNeill; Sascha Grabow; Christoph Reimertz; Christoph Nau; Michelle Klos; Andreas Reif
Journal:  J Clin Med       Date:  2019-10-08       Impact factor: 4.241

5.  Methylphenidate Use and Infectious Diseases in Children With Attention Deficit and Hyperactivity Disorder: A Population-Based Study.

Authors:  Vincent Chin-Hung Chen; Kai-Liang Kao; Yi-Lung Chen; Shu-I Wu; Min-Jing Lee; Michael Gossop
Journal:  Front Med (Lausanne)       Date:  2022-02-08

6.  Methylphenidate and TBI in ADHD and co-occurring epilepsy and mental disorders: a self-controlled case series study.

Authors:  Vincent Chin-Hung Chen; Yao-Hsu Yang; Charles Tzu-Chi Lee; Yi-Lung Chen; Michael E Dewey; Michael Gossop
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-01-02       Impact factor: 4.785

7.  Prevalence of Attention Deficit Hyperactivity Disorder Symptoms in Children Who Were Treated at Emergency Service due to Unintentional Injury.

Authors:  Mehmet İz; Veysi Çeri
Journal:  Emerg Med Int       Date:  2018-12-12       Impact factor: 1.112

8.  Treatment with Methylphenidate for Attention Deficit Hyperactivity Disorder (ADHD) and the Risk of All-Cause Poisoning in Children and Adolescents: A Self-Controlled Case Series Study.

Authors:  Le Gao; Kenneth K C Man; Esther W Chan; Celine S L Chui; Xue Li; David Coghill; Kam Lun Hon; Man Li Tse; Terry Y S Lum; Kirstie H T W Wong; Patrick Ip; Ian C K Wong
Journal:  CNS Drugs       Date:  2021-07-20       Impact factor: 5.749

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.